Status:
RECRUITING
Study on Clinical Features and Outcomes of Breast Sarcoma
Lead Sponsor:
Italian Sarcoma Group
Conditions:
Breast Sarcoma
Eligibility:
All Genders
19+ years
Brief Summary
This is multi-institutional retrospective study in order to identify the most relevant clinical characteristics, treatment strategies, to explore the impact on principal clinical outcomes and finally,...
Detailed Description
In the field of soft tissue sarcomas, breast sarcomas are a truly peculiar family of rare tumors for both their clinical history and biology of disease. Surgery (if feasible) is the main therapeutic ...
Eligibility Criteria
Inclusion
- \>18 years at diagnosis
- primary or secondary breast sarcoma
- availability of medical data needed for the study (histopathological data, surgery, chemotherapy, including preceding chemotherapeutic regimens for secondary breast sarcomas, radiation therapy)
Exclusion
- sarcoma metastases to the breast
- chest wall sarcomas not arising in the mammary gland
- cutaneous sarcomas
Key Trial Info
Start Date :
April 2 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04749446
Start Date
April 2 2021
End Date
December 1 2026
Last Update
January 2 2026
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera S. Orsola-Malpighi
Bologna, BO, Italy, 40138
2
Istituto Europeo di Oncologia
Milan, MI, Italy, 20141
3
Istituto Clinico Humanitas
Rozzano, MI, Italy, 20089
4
Azienda Ospedaliera Universitaria Paolo Giaccone
Palermo, PA, Italy, 90127